Silicon Valley, Oxford Provide $42MM Facility to Ignyta
Ignyta secured a $42 million term loan facility from Silicon Valley Bank and Oxford Finance.
Ignyta secured a $42 million term loan facility from Silicon Valley Bank and Oxford Finance.
Oxford Finance closed a $10 million term loan to Monteris Medical. Proceeds of the loan are being used to accelerate the ongoing sales of its NeuroBlate System, a laserablation device used to treat brain lesions.
Regulus Therapeutics has entered into a $30 million loan agreement with Oxford Finance that will be used to provide working capital for the advancement of its clinical and pre-clinical development pipeline.
Empire Resources entered a second amendment to its existing A&R credit agreement, agented by Rabobank, New York branch. Its credit facility was reduced by $22.5 million to $162.5 million.
Halozyme Therapeutics entered into an agreement with Oxford Finance and Silicon Valley Bank to refinance its existing senior secured loan facility.
Omeros has entered into an amendment to its existing credit facility with Oxford Finance and East West Bank. The banks will provide an additional $20 million in unrestricted cash by funding the remaining tranches of the existing facility.
Oxford Finance closed a senior credit facility with Diversis Capital. Funds were used to acquire Caligor Rx, a provider of comparator drugs for clinical trials.
Oxford Finance and Silicon Valley Bank closed a $45 million term loan to Nuvectra. The facility is comprised of a $40 million senior secured term loan and a $5 million line of credit.
HTG Molecular has borrowed $5 million under the second part of an agreement providing two separate term loans from Oxford Finance and Silicon Valley Bank.
Oxford Finance closed a $27 million term loan to Cascade Capital Group. The funds were used to purchase three skilled nursing facilities.